A Strategy of Home Telehealth for Management of Congestive Heart Failure(STARTEL)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00247000|
Recruitment Status : Unknown
Verified February 2006 by Nova Scotia Health Authority.
Recruitment status was: Not yet recruiting
First Posted : November 1, 2005
Last Update Posted : June 28, 2007
|Condition or disease||Intervention/treatment||Phase|
|Heart Failure||Device: Routine Care in a HF clinic vs Home Telehealth Care for HF||Phase 4|
We plan to implement and evaluate a Home Telehealth Care Management System designed to enhance clinical care for congestive heart failure patients who have difficulty with access to care. Unique in this model is that in addition to use of protocol driven interventions (evidence based), the primary care physician is intimately involved in follwo up of patients- with consequent reduction in the fracture of care seen in with attendance in multiple specialty clinics.
In this project, we will evaluate the delivery of care to heart failure patients in Nova Scotia and New Brunswick, with our intervention and the current standard of care, which is the heart failure clinic. Home Telehealth technology will allow patients to be contacted and regularly evaluated in a comprehensive way in their own home, and without the need for a clinic visit. While the Project Team (experienced in heart failure management) will monitor all data, the Family Physician will have first hand access to and right of first treatment when alterations in therapy are needed. This process will be facilitated by the use of protocol driven medical therapy, and delegated medical functions, as well as set-piece education. We hope, with this technology and care plan, to offer the benefits of disease management to this vulnerable patient population while at the same time firmly placing the Family Physician in their central role within the health care system. This program will enable a specific assessment of all aspects of the program, including outcomes, quality of life, professional satisfaction and cost.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||150 participants|
|Intervention Model:||Factorial Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Strategy of Home Telehealth for Management of Congestive Heart Failure: STARTEL|
|Study Start Date :||September 2007|
|Study Completion Date :||November 2007|
- A composite of total all-cause hospitalizations and total mortality at one year.
- Heart failure morbidity and mortality
- Cardiovascular hospitalization
- Total number days in hospital
- Total outpatient physician visits
- Number of non-scheduled health visits outside the home
- Total inpatient and outpatient health care costs
- Kansas City Cardiomyopathy Quality of Life Score
- Total medication related costs
- Medication adherence(by prescription filling data)
- Patient satisfaction as measured on Likert scale(1-10)
- Primary care physician satisfaction (Likert scale)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00247000
|Contact: Jonathan G Howlett, M.D.,FRCPCemail@example.com|
|Contact: Michelle T Currie, RNfirstname.lastname@example.org|
|Canada, New Brunswick|
|New Brunswick Heart Centre, Atlantic Health Sciences Corporation|
|Saint John, New Brunswick, Canada, B2L 4L2|
|Contact: Krisan Palmer, RN 506-648-7342 email@example.com|
|Sub-Investigator: David Marr, M.D.,FRCPC|
|Principal Investigator:||Jonathan G Howlett, M.D.,FRCPC||Capital District Health Authority, QEII Health Sciences Centre|